Eli Lilly
LLYUSAGlobal biopharmaceutical company and largest healthcare constituent in the S&P 500.
0.00%
All-Time High
As of Oct 29, 2026, Eli Lilly (LLY) closed at $1,373.70, trading at an all-time high.
Current Drawdown
0.00%
From all-time highLast Close
$1,373.70
Oct 29, 2026
All-Time High
$1,373.70
Oct 29, 2026
Days Below Peak
0d
At peak todayGain to ATH
At Peak (0%)
Trading at ATHLoading chart…
Set Drawdown Alert
Get notified when Eli Lilly dips below your chosen threshold.
Benchmark Indexes Where Eli Lilly is a Top Holding
Compare Eli Lilly (LLY) at 0.00% against the major equity indexes it anchors.
Historical Maximum Drawdowns & Annual Drops
Deepest peak-to-trough drop recorded within each calendar year.
Over the last 10 completed years, Eli Lilly experienced an average intra-year drawdown of -18.7% lasting an average of 69 days peak-to-trough, with its deepest drawdown reaching -32.7% in 2025.
10Y Avg Drawdown
-18.74%
Pullback
Deepest Drawdown
-32.71%
2025 · Correction
Avg Peak-to-Trough
69 days
| Year | Max Intra-Year Drawdown | Peak High | Bottom Trough | Peak-to-Trough | Yearly Return |
|---|---|---|---|---|---|
| 2025 | -32.71%Correction | Mar 3, 2025 $929.72 | Aug 8, 2025 $625.65 | 158 days | +39.21% |
| 2024 | -24.25%Correction | Aug 30, 2024 $960.02 | Nov 18, 2024 $727.20 | 80 days | +32.44% |
| 2023 | -14.89%Pullback | Jan 3, 2023 $364.99 | Mar 7, 2023 $310.63 | 63 days | +59.34% |
| 2022 | -13.63%Pullback | Jan 3, 2022 $271.73 | Feb 14, 2022 $234.69 | 42 days | +32.45% |
| 2021 | -18.74%Pullback | Aug 17, 2021 $272.71 | Sep 28, 2021 $221.60 | 42 days | +63.60% |
| 2020 | -22.86%Correction | Jul 8, 2020 $169.13 | Oct 30, 2020 $130.46 | 114 days | +28.46% |
| 2019 | -18.49%Pullback | Mar 26, 2019 $131.02 | Jul 19, 2019 $106.79 | 115 days | +13.58% |
| 2018 | -15.29%Pullback | Jan 29, 2018 $87.60 | Feb 8, 2018 $74.21 | 10 days | +37.01% |
| 2017 | -10.75%Pullback | Apr 12, 2017 $86.25 | May 22, 2017 $76.98 | 40 days | +14.83% |
| 2016 | -15.84%Pullback | Nov 9, 2016 $78.39 | Dec 1, 2016 $65.97 | 22 days | -4.18% |
Compare with Other Drawdowns
Frequently Asked Questions about Eli Lilly
Click to expandHow is the current drawdown of Eli Lilly calculated?
Because Eli Lilly's latest official daily closing price of $1,373.70 matches its all-time high, the current drawdown is 0.00% (trading at peak valuation). When a new high is printed, the drawdown resets to zero.
At what prices does Eli Lilly enter a dip, pullback, correction, or bear market?
Measuring from Eli Lilly's all-time high closing price of $1,373.70:
• -10% Dip: Triggers at $1,236.33
• -20% Pullback: Triggers at $1,098.96
• -35% Correction: Triggers at $892.91
• -35% Bear Market: Triggers at $892.91
At its latest close of $1,373.70 (0.00%), Eli Lilly is currently in All-Time High territory (Currently trading at peak all-time high price.).
How much does Eli Lilly need to rise to reach a new all-time high?
Eli Lilly is currently trading at its all-time high of $1,373.70. Any subsequent upward movement marks unchartered price discovery in new all-time high territory.
What is the typical annual drawdown and duration for Eli Lilly?
Across completed annual calendar cycles, Eli Lilly experienced an average intra-year pullback of -18.7%, taking an average of 69 calendar days to reach bottom from its intra-year peak. The deepest annual decline occurred in 2025 with a -32.7% drop, while the mildest year was 2017 with a pullback of only -10.8%.
What is the historical maximum drawdown for Eli Lilly?
The maximum historical drawdown recorded for Eli Lilly across tracked cycles is -34.83%. In recent market history, its deepest calendar year decline occurred in 2025, falling -32.7% from $929.72 (Mar 3, 2025) down to a trough of $625.65 (Aug 8, 2025), spanning 158 days from peak to bottom.
Which benchmark stock indexes include Eli Lilly as a top holding?
Eli Lilly (LLY) is tracked as a top constituent holding in 1 major benchmark index:
• S&P 500 (^GSPC): currently at -1.26% drawdown
Educational & Informational Purpose Only: All data shown is for informational purposes only and does not constitute financial advice. Past drawdowns and recoveries are not indicative of future returns. See our Terms of Service for full disclaimers.